Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sylvie Gouva"'
Autor:
Karim Amrane, Margaux Geier, Romain Corre, Hervé Léna, Guillaume Léveiller, Florence Gadby, Régine Lamy, Jean‐Louis Bizec, Eric Goarant, Gilles Robinet, Sylvie Gouva, Gilles Quere, Ronan Abgral, Ulrike Schick, Cyril Bernier, Christos Chouaid, Renaud Descourt
Publikováno v:
Cancer Medicine, Vol 9, Iss 7, Pp 2309-2316 (2020)
Abstract Background The KEYNOTE‐024 trial demonstrated that pembrolizumab, a PD‐1 inhibitor, significantly improves progression‐free survival (PFS) and overall survival (OS) in selected patients with previously untreated advanced non–small ce
Externí odkaz:
https://doaj.org/article/c98d4e070de24144a3c13472f5f9c857
Autor:
Elisabeth Gaye, Sylvie Gouva, Marine Guilloïque, Gilles Quere, Renaud Descourt, François Lucia, Margaux Geier, Paul Bore, Gilles Robinet
Publikováno v:
Lung Cancer. 133:1-3
Objectives Brigatinib is a second-generation ALK inhibitor which demonstrated activity over crizotinib-resistance, especially on brain metastasis by increased blood-brain penetration. However, its activity on lepto-meningeal disease is unknown and sc
Autor:
Olivier Delcroix, Gilles Quere, Ronan Abgral, Sylvie Gouva, Nathalie Keromnes, Karim Amrane, Ulrike Schick, Pierre-Yves Salaun, Zarrin Alavi, Delphine Le Goupil, Solène Querellou
Publikováno v:
Medicine
We aimed to assess serial 18F-FDG PET/CT imaging according to morphological (RECIST1.1, iRECIST) and functional (PERCIST, PECRIT) criteria to predict clinical response to therapy in patients with advanced melanoma receiving immune checkpoint blocking
Publikováno v:
Bulletin du Cancer. 98:1107-1118
Taking care of patients in oncology needs safety venous access, as percutaneous implantable port. These venous devices are sometimes responsible for serious adverse events. Infection and thrombosis are the two main complications that can occur early
Autor:
Pascal Thomas, Gilles Robinet, P. Bombaron, Maurice Pérol, Sylvie Gouva, Pierre Fournel, Hervé Lena, Jean-Pierre Kleisbauer, H. Le Caer, Henri Berard, A. Vergnenegre
Publikováno v:
Lung Cancer. 51:105-114
Summary Purpose To evaluate the efficacy and safety of gemcitabine and carboplatin in the treatment of previously untreated patients with advanced non-small cell lung cancer (NSCLC). Methods A randomized phase II study was conducted by the Groupe Fra
Autor:
Georges Tymen, H. Baysson, Dominique Laurier, Margot Tirmarche, Jean-Claude Artus, Françoise Ducloy, Alain Vergnenegre, Denis Caillaud, Sylvie Gouva
Publikováno v:
Epidemiology. 15:709-716
Several case-control studies have indicated an increased risk of lung cancer linked to indoor radon exposure; others have not supported this hypothesis, partly because of a lack of statistical power. As part of a large European project, a hospital-ba
Autor:
Alain Depierre, François Blanchon, Bernard Milleron, Marie-Claude Level, Etienne Lemarié, Jeanne-Marie Bréchot, Sylvie Chevret, Jean-Michel Rodier, D. Moro-Sibilot, François-Xavier Lebas, B. Lebeau, Nadine Paillot, Pascal Leclerc, Jean Clavier, Michel Monchâtre, Anne Villeneuve, Pascal Foucher, Virginie Westeel, Elisabeth Quoix, Sylvie Gouva, Claude Chastang, D. Coëtmeur, Denis Braun, Philippe Terrioux, Jean-Luc Breton, H. Janicot, Luc Thiberville
Publikováno v:
Journal of Clinical Oncology. 20:247-253
To evaluate whether preoperative chemotherapy (PCT) could improve survival in resectable stage I (except T1N0), II, and IIIA non-small-cell lung cancer (NSCLC).A randomized trial compared PCT to primary surgery (PRS). PCT consisted of two cycles of m
Publikováno v:
Bulletin du cancer. 98(9)
Taking care of patients in oncology needs safety venous access, as percutaneous implantable port. These venous devices are sometimes responsible for serious adverse events. Infection and thrombosis are the two main complications that can occur early
Autor:
C. Penot-Ragon, D. Paillotin, P. Balmes, P. Delaval, François Blanchon, J. F. Muir, D. Perdu, Hervé Lena, Sylvie Gouva, R. Poirier, P. Pommier de Santi, Pascal Thomas, O. Castelnau, Jean-Pierre Kleisbauer, Gilles Robinet
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(5)
PURPOSE: To evaluate the efficacy and safety of paclitaxel and carboplatin in the treatment of previously untreated patients with metastatic small-cell lung cancer (SCLC). PATIENTS AND METHODS: Eligible patients were aged 18 to 75 years with an Easte
Autor:
Elisabeth Quoix, Jean-Luc Breton, Denis Moro-Sibilot, Etienne Lemarié, Alain Depierre, Bernard Lebeau, Virginie Westeel, Bernard Milleron, Denis Braun, Sylvie Gouva
Publikováno v:
Lung Cancer. 41:S62